Humana reaffirms FY 2024 GAAP EPS guidance of ~$14.87 and adjusted EPS ~$16.00

HUMANA INC

Reaffirms FY 2024 GAAP diluted EPS guidance of approximately $14.87.
Reaffirms adjusted (non-GAAP) EPS guidance of approximately $16.00, unchanged from Jan 25.
Adjustments include $0.49 amortization, $0.97 for exit of employer group commercial medical, and ($0.33) net tax impact.
Management meeting with investors at industry conference from Mar 5-31.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.